Iterum Therapeutics plc (ITRM)

USD 1.67

(-8.74%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - 37 Thousand 869 Thousand
Cost of Revenue 1.75 Million 1.8 Million 2.1 Million 161 Thousand - -
Gross Profit -1.75 Million -1.8 Million -2.1 Million -161 Thousand 37 Thousand 869 Thousand
Operating Expenses 47.46 Million 30.38 Million 24.53 Million 32.12 Million 102.05 Million 77.42 Million
Selling, General and Administrative Expenses 7.47 Million 12.76 Million 13.82 Million 11.05 Million 11.28 Million 8.78 Million
Research and Development Expenses 39.99 Million 17.61 Million 10.71 Million 21.07 Million 90.77 Million 68.64 Million
Other Expenses - -16.84 Million 195 Thousand 213 Thousand 196 Thousand 401 Thousand
Cost and Expenses 47.46 Million 30.38 Million 24.53 Million 32.12 Million 102.05 Million 77.42 Million
Operating Income -47.46 Million -30.38 Million -24.53 Million -32.12 Million -102.02 Million -76.55 Million
Interest Expense - 2.36 Million 5.55 Million 15.09 Million 861 Thousand 426 Thousand
Income Tax Expense 613 Thousand 301 Thousand 705 Thousand 743 Thousand 444 Thousand 472 Thousand
Earnings before Tax -37.75 Million -44.13 Million -90.85 Million -51.26 Million -102.68 Million -76.58 Million
Net Income -38.37 Million -44.43 Million -91.56 Million -52 Million -103.13 Million -77.05 Million
Earnings Per Share Basic -2.96 -3.63 -0.56 -2.17 -7.10 -132.34
Earnings Per Share Diluted -2.96 -3.63 -0.56 -2.17 -7.10 -132.34
Weighted Average Shares Outstanding 12.96 Million 12.23 Million 163.36 Million 24 Million 14.51 Million 582.27 Thousand
Weighted Average Shares Outstanding (Diluted) 12.96 Million 12.23 Million 163.36 Million 24 Million 14.51 Million 582.27 Thousand
Gross Margin - - - - 1.00 1.00
EBIT Margin - - - - -2752.03 -87.64
Profit Margin - - - - -2787.30 -88.67
EBITDA -34.58 Million -39.97 Million -83.2 Million -36 Million -101.67 Million -76.02 Million
Earnings Before Tax Margin - - - - -2757.32 -88.10

Income Statement Charts